(Total Views: 687)
Posted On: 12/05/2019 12:00:43 PM
Post# of 121

$ONCS News Article - OncoSec to Present Interim Data from Ongoing KEYNOTE-890 Study of TAVO(TM) and KEYTRUDA in Late-Stage Metastatic Triple Negative Breast Cancer at the 2019 San Antonio Breast Cancer Symposium https://marketwirenews.com/news-releases/onco...99545.html


My Twitter: WhyteStocks